Korean clinical trials: its current status, future prospects, and enabling environment
10.12793/tcp.2019.27.4.115
- Author:
Dong Hyun CHEE
1
Author Information
1. Korea National Enterprise for Clinical Trials, KoNECT, Seoul 04143, Korea. deborah.chee@konect.or.kr
- Publication Type:Brief Communication
- From:Translational and Clinical Pharmacology
2019;27(4):115-118
- CountryRepublic of Korea
- Language:English
-
Abstract:
No abstract available.